Questionable Survival Benefit of Aspirin Use in Patients With Biliary Tract Cancer-Reply
- PMID: 32191283
- PMCID: PMC8577547
- DOI: 10.1001/jamaoncol.2020.0125
Questionable Survival Benefit of Aspirin Use in Patients With Biliary Tract Cancer-Reply
Conflict of interest statement
Comment on
-
Association Between Aspirin Use and Biliary Tract Cancer Survival.JAMA Oncol. 2019 Dec 1;5(12):1802-1804. doi: 10.1001/jamaoncol.2019.4328. JAMA Oncol. 2019. PMID: 31621809 Free PMC article.
-
Questionable Survival Benefit of Aspirin Use in Patients With Biliary Tract Cancer.JAMA Oncol. 2020 May 1;6(5):783-784. doi: 10.1001/jamaoncol.2020.0122. JAMA Oncol. 2020. PMID: 32191269 No abstract available.
References
-
- Surveillance E, and End Results (SEER) Program (www.seer.cancer.gov). SEER*Stat Database: Incidence - SEER 9 Regs Research Data, Nov 2018 Sub (1975-2016) <Katrina/Rita Population Adjustment> - Linked To County Attributes - Total U.S., 1969-2017 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2019, based on the November 2018. submission.
-
- Strom BL, Kimmel SE, Hennessy S. Pharmacoepidemiology. Sixth edition. ed. Hoboken, NJ: Wiley-Blackwell; 2020.
-
- McDonald L, Schultze A, Carroll R, Ramagopalan SV. Performing studies using the UK Clinical Practice Research Datalink: to link or not to link? Eur J Epidemiol. 2018;33(6):601–605. - PubMed
